Life sciences focus Burns McClellan specializes in public and investor relations for life sciences and healthcare, indicating a deep domain expertise and potential cross-sell opportunities to portfolio companies across pharma, biotech, medical devices, and diagnostics.

New York base with global reach Headquartered in NYC with a partnership network through Hume Brophy, the firm can offer global PR and IR services, suggesting upsell potential to clients seeking international expansion and cross-border communications.

Mid-market scale With 11-50 employees and annual revenue in the mid-range, Burns McClellan fits mid-market life sciences clients; this presents opportunities to expand services such as integrated marketing, regulatory affairs communications, and investor relations for growing companies.

Digital and content stack The use of WordPress, SEO tooling, and standard web technologies points to a capability in digital communications, content strategy, and online reputation management that can be leveraged for comprehensive campaigns and thought leadership programs.

Competitive positioning Operating alongside larger firms with substantial resources, Burns McClellan can position itself as a specialized, agile partner for niche life sciences firms seeking tailored strategy, faster execution, and focused investor relations and media outreach.